“…Finally, in 1,7bis [2-(methylsulfanyl)ethyl]-4,10,diacetic acid-1,4,7,10-tetraazacyclododecane (DO2A2S), the two opposite carboxylic arms of DOTA have been replaced with sulfur-containing ones, to produce a chelator with hybrid coordination capability between DOTA and DO4S (Figure 1D) [32]. In the second series, the effect of the ring size on the properties of the resulting copper complexes was considered, leading to 1,4,7,10-tetrakis [2-(methylsulfanyl)ethyl]-1,4,7,10-tetrazacyclotridecane (TRI4S) and 1,4,8,11-tetrakis [2-(methylsulfanyl)ethyl]-1,4,8,11tetrazacyclotetradecane (TE4S) (Figure 1E) [33]. As a result, the thermodynamic, kinetic and structural properties of the Cu 2+/+ complexes formed with these sulfur-bearing ligands were investigated demonstrating that they can be promising scaffolds for cutting-edge copper-based radiopharmaceuticals [1,33].…”